Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 46
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Should I stay or should I go? Connecting bird behavior during migration to fat stores and antioxidant capacity

    Thank you to our backers for $5600! We actually need up to $24000 - please keep donating! In the fall, most...

    How Will Global Climate Change Impact Tropical Communities?

    Parasitoid diversity is rapidly declining in La Selva Costa Rica, yet many species remain undescribed limiting...

    Backer Badge Funded